Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy
Author:
Affiliation:
1. University of Birmingham and Heart of England NHS Foundation Trust, Birmingham, UK
Publisher
Informa Healthcare
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1185/03007991003738063
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Metformin: A potential adjunct for treatment of systemic mastocytosis;Journal of Allergy and Clinical Immunology: Global;2024-02
2. Risk prediction for severe hypoglycemia in a type 2 diabetes population with previous non-severe hypoglycemia;Journal of Diabetes and its Complications;2020-01
3. Metformin, an Anti-diabetic Drug to Target Leukemia;Frontiers in Endocrinology;2018-08-10
4. Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2016-07
5. Le diabète de type 2 au stade de l’insuline : Quelle place pour les inhibiteurs de la DPP-4 ?;Médecine des Maladies Métaboliques;2015-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3